Ultra-High Yield Dividend Stocks Yielding More Than 5%

Photo of Vandita Jadeja
By Vandita Jadeja Published

Quick Read

  • Pfizer jumped 10% on strong Q4 results and will initiate 20 Phase 3 drug trials in 2026.

  • Realty Income has increased dividends for 113 consecutive quarters and pays monthly dividends.

  • Enterprise Products Partners forecasts 3% to 5% cash flow growth in 2026 but double-digit growth in 2027.

  • Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.(Sponsor)

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Ultra-High Yield Dividend Stocks Yielding More Than 5%

© ShutterstockProfessional / Shutterstock.com

Choosing the right investment vehicles can ensure steady income and wealth generation. Growth stocks are often considered to be an ideal choice for younger investors, but those of you approaching or already in retirement, there is no shortage of high-quality dividend stocks with strong track records, stability and growth potential.

Dividends can generate wealth for you in the long term. So if you’re looking to build passive income for 2026, investing in ultra-high yield dividend stocks can help shore up your plan. Some of these stocks pay monthly dividends, making them an ideal option for income seekers.

If this sounds like you, consider adding Pfizer (NYSE: PFE), Realty Income (NYSE:O) and Enterprise Products Partners (NYSE:EPD | EPD Price Prediction) to your portfolio. Here’s why.

Pfizer Inc. 

Dividend yield: 6.23%

Pfizer Inc. is a hot stock today and is trading at the 52-week high. After the fourth-quarter results, the stock jumped 10% and is exchanging hands for $27.61. It has a juicy yield of 6.23% and has raised dividends for 15 consecutive years. The stock has a payout ratio of 53.25% and pays an annual dividend of $1.72 per share.

The strong quarterly numbers are a sign that the stock is ready for a rebound. Pfizer has suffered longer than it deserved to, but it has the ability to bounce back from the lows. Its fourth-quarter EPS came in at $1.36, and the revenue stood at $17.56 billion, down 2% year over year. The company was behind in the GLP race, which led to the acquisition of Metsera, which adds a promising drug pipeline to its portfolio. 

For 2026, it expects an EPS in the range of $2.80 to $3. Its rich pipeline of drugs could make it a winner this year. The company has 102 ongoing trials and 32 in phase 3. It expects to initiate about 20 Phase 3 trials this year. With several late-stage trials ongoing, there’s a reason to be optimistic about the future of the stock. 

I’ve always been certain that the company can survive any headwinds as a business. Pfizer is in a strong position and has a solid pipeline that can continue generating revenue. The stock upside might be limited, but the dividend is secure.

Realty Income

Dividend yield: 5.05%

Realty Income is a real estate investment trust (REIT) that offers a juicy yield of 5.05% and pays monthly dividends. It is known as “The Monthly Dividend Company” and has increased dividends for 113 consecutive quarters. The company owns a portfolio of more than 15,000 commercial real estate properties across 92 industries. It follows a triple-net lease structure, which helps keep the operation costs down while generating steady cash flow. 

An REIT is required to distribute at least 90% of its taxable income as dividends to the shareholders. A top dividend stock to buy, Realty Income stock is exchanging hands for $63.90 and is up 17.5% in the year. The stock has a payout ratio of 75.27% and pays $3.24 per share in annual dividends. Realty Income’s monthly dividends can compound and generate significant income growth for you.

An income juggernaut, Realty Income is on rock-solid ground. It has one of the best balance sheets in the industry and has a business model that continues to generate cash while keeping the expenses at bay. The REIT has entered into a partnership with Singapore’s sovereign wealth fund, GIC, and has committed about $1.5 billion to build logistics properties. It has also announced its first investment in Mexico, taking a meaningful step in its diversification strategy. 

With a geographically diversified portfolio, Realty Income has ensured steady passive income irrespective of the market ups and downs. 

Enterprise Products Partners

Dividend yield: 6.25%

One of the largest midstream energy companies, Enterprise Products Partners is a master limited partnership (MLP) with approximately 50,000 miles of pipeline. The company has increased dividends for 27 consecutive years and enjoys a yield of 6.25%.

Like REITs, MLPs are tax pass-through entities, which enables them to pay shareholders sizable dividends. 

EDP has a payout ratio of 81.18% and pays $2.20 per share in annual dividend. The oil and gas pipeline operator generates a large part of the revenue from long-term, fee-based contracts that are tied to the volume instead of oil and gas prices. 

2026 could be a good year for the company as it continues to work towards organic growth projects. The company expects to spend $2.5 billion in 2026 towards capital expenditure, and as new projects come online, it will be able to distribute higher dividends. In the fourth quarter, the company saw a 4% rise in gross operating profit to $2.74 billion, and the free cash flow came in at $1.17 billion.

The company has about $4.8 billion worth of projects underway, and it plans to export 1.5 million barrels per day of natural gas liquids this year. For 2026, the management has forecasted a cash flow growth at the lower end of the 3% to 5% range. 

However, it is projecting a double-digit growth for 2027 as new projects come online. 2025 wasn’t easy for Enterprise Product Partners, but it is in a much better position today. The company is looking at new projects for 2027, and this could ramp up growth. 

Photo of Vandita Jadeja
About the Author Vandita Jadeja →

Vandita Jadeja is a financial copywriter who loves to read and write about stocks. She believes in buying and holding for long term gains. Her knowledge of words and numbers helps her write clear stock analysis. She has contributed to several publications, including the Joy Wallet, Benzinga, The Motley Fool and InvestorPlace.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

SMCI Vol: 62,670,203
+$1.83
+8.23%
$24.06
HPE Vol: 51,563,427
+$1.88
+7.87%
$25.78
AMD
AMD Vol: 47,796,359
+$14.90
+7.26%
$220.27
INTC Vol: 96,830,792
+$3.12
+7.08%
$47.18
FICO Vol: 332,141
+$48.10
+4.83%
$1,043.10

Top Losing Stocks

VRSK Vol: 2,716,486
-$9.68
4.97%
$185.05
PODD Vol: 925,577
-$9.79
4.34%
$215.71
MU Vol: 54,333,216
-$13.44
3.40%
$382.09
BRO Vol: 5,106,136
-$2.21
3.32%
$64.29
-$1.54
3.13%
$47.60